Evidence map›Paper›PMID 41496453›Full record

ArticleBiophysical journal2026

Systems-level consequences of low RAF abundance for EGFR-ERK signaling.

Sung Hyun Lee, Paul J Myers, Max C Mendrzycki, Kevin S Brown, Leslie M Loew, Alexander Sorkin, Matthew J Lazzara

Abstract read
In one paragraph

Article in Biophysical journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors.

Sung Hyun LeeDepartment of Chemical Engineering, University of Virginia, Charlottesville, Virginia.
Paul J MyersDepartment of Chemical Engineering, University of Virginia, Charlottesville, Virginia.
Max C MendrzyckiDepartment of Chemical Engineering, University of Virginia, Charlottesville, Virginia.
Kevin S BrownDepartment of Pharmaceutical Sciences and School of Chemical, Biological, and Environmental Engineering, Oregon State University, Corvallis, Oregon.
Leslie M LoewRichard D. Berlin Center for Cell Analysis and Modeling, University of Connecticut School of Medicine, Center for Cell Analysis and Modeling, UConn Health, 263 Farmington Avenue, Farmington, Connecticut.
Alexander SorkinDepartment of Cell Biology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.
Matthew J LazzaraDepartment of Chemical Engineering, University of Virginia, Charlottesville, Virginia; Department of Biomedical Engineering, University of Virginia, Charlottesville, Virginia. Electronic address: mlazzara@virginia.edu.

Funding

Systems Analysis of Stress-adapted Cancer Organelles (SASCO) CenterU54CA274499 · NCI · UNIVERSITY OF VIRGINIA · PI Kevin A Janes · 2022 to 2026
$13.4M
Mechanistic Modeling of Cellular SystemsR24GM137787 · NIGMS · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI Pedro Mendes, Ion I. Moraru · 2020 to 2026
$8.9M
R35 - ADMIN SUPPLEMENT - EGF Receptor Endocytosis: Mechanisms and Role in SignalingR35GM148363 · NIGMS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI ALEXANDER D SORKIN · 2023 to 2026
$1.8M
Transdisciplinary Big Data Science Training at UVaT32LM012416 · NLM · UNIVERSITY OF VIRGINIA · PI BROWN, DONALD E, LOUGHRAN, THOMAS P. · 2016 to 2020
$1.3M
NCI NIH HHS U54 CA274499NIGMS NIH HHS R24 GM137787NIGMS NIH HHS R35 GM148363NLM NIH HHS T32 LM012416
6 · The paper itself

Abstract

RAFs initiate the cascade leading to activation of the extracellular signal-regulated kinases (ERKs). In a substantial fraction of cancer cells, RAFs are the least abundant pathway proteins between receptor tyrosine kinases and ERKs. In some cases, active RAF kinases are present at the plasma membrane at just hundreds of copies per cell, but the consequences of such limited RAF abundance are unclear. By developing continuum and stochastic computational models of the epidermal growth factor receptor (EGFR)-ERK pathway, we showed that low RAF abundance creates signaling bottlenecks between receptor tyrosine kinases and ERK with a potential for stochastic RAF dynamics that can propagate especially to low-abundance downstream pathway proteins. RAF bottlenecks were also predicted to impede ERK activation by oncogenic RAS mutants. Advanced parameter sensitivity and sloppiness analyses identified RAS activation and RAS-RAF interactions as strong determinants of signaling in low-RAF settings and revealed an efficient model fitting approach. This work provides quantitative insight into a common, but unexplored, regime for EGFR-ERK signaling and a systematic approach to develop and characterize dynamic models of receptor-mediated signaling.

Indexed as

ErbB ReceptorsExtracellular Signal-Regulated MAP KinasesMAP Kinase Signaling SystemModels, Biologicalraf KinasesSignal TransductionAnimalsEnzyme ActivationHumansMutationras ProteinsStochastic ProcessesErbB ReceptorsExtracellular Signal-Regulated MAP Kinasesraf Kinasesras Proteins

Identifiers

PMID41496453
PMCPMC13093192

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.